<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel>
<title><![CDATA[Editorial Board of Journal of Pharmaceutical Research -->Early Online Releases]]></title>
<item>
<title><![CDATA[Neuroprotective effects of Zhinao Capsule against cerebral ischemia-reperfusion injury in rats and its anti-apoptotic mechanisms]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202601310000001&flag=2]]></link>
<description><![CDATA[Objective To investigate the preventive neuroprotective effects of Zhinao Capsule on cerebral ischemia–reperfusion injury (CIRI) in rats and to explore its anti-apoptotic mechanisms. Methods  Male Sprague-Dawley rats were randomly divided into a sham-operated group, a model group, and low-, medium-, and high-dose Zhinao Capsule groups (0.234, 0.468, and 0.936 g·kg-1). Except for the sham group, a CIRI model was established by right middle cerebral artery occlusion. Zhinao Capsule was administered by gavage for 7 consecutive days prior to model induction. Following the establishment of the CIRI model, the degree of cerebral injury, histopathological alterations, oxidative stress profiles, and inflammatory cytokine levels, and apoptosis-related protein expression were comprehensively evaluated. Results  Compared with the model group, the medium- and high-dose Zhinao Capsule groups showed significantly reduced cerebral infarct areas and improved neurological function scores (P<0.05), accompanied by alleviated histopathological damage and enhanced microtubule-associated protein 2 (MAP2) expression. Malondialdehyde (MDA) levels decreased, while superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities significantly increased across all treatment groups, and inflammatory cytokines levels were markedly reduced (P<0.05). The expression levels of phosphorylated phosphatidylinositol-3-kinase (PI3K) and phosphorylated protein kinase B (AKT) proteins were upregulated in all dosage groups, while glycogen synthase kinase-3β (GSK-3β) expression was downregulated. Concurrently, apoptosis-related proteins B-cell lymphoma factor-2 (Bcl-2) expression increased, whereas Bcl-2-related X protein (Bax) and cysteine aspartate protease-3 (Caspase-3) expression decreased, and the number of TUNEL-positive cells was significantly reduced (P<0.05). Conclusion  Zhinao Capsule can alleviate CIRI in rats and protect damaged neurons, likely by reducing oxidative stress, suppressing neuroinflammation, and activating the PI3K/AKT/GSK-3β signaling pathway.]]></description>
<pubDate>2026/6/15 16:34:54</pubDate>
<category><![CDATA[实验研究]]></category>
<author><![CDATA[CHENG Ting,HU Kexin,HU Xi,LI Wenlong,WANG Chunge,ZHANG Jingxin]]></author>
</item>
<item>
<title><![CDATA[Construction of a Three-Tier Prevention System for Helicobacter pylori Infection]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202603220000001&flag=2]]></link>
<description><![CDATA[Helicobacter pylori (H. pylori) infection is the most significant modifiable risk factor for gastric cancer. However, escalating antibiotic resistance, uneven healthcare resource distribution, and post-eradication recurrence render antibiotic-centered strategies alone insufficient. Drawing on gastric cancer prevention frameworks and integrating the traditional Chinese medicine concept of “preventive treatment of disease” (Zhi Wei Bing), this paper proposes a three-tier prevention system for whole-process management of H. pylori infection. Guided by the One Health approach, primary prevention focuses on blocking transmission while designating the oral cavity as an intervention “sentinel”. Secondary prevention stratifies infected individuals into Category A (mandatory eradication) and Category B (“four no-kill” scenarios: unsuitable, deferred, resistant, and unwilling), shifting from eradication-centered to health-centered management. Tertiary prevention emphasizes post-eradication holistic recovery with dynamic re-stratification — recrudescence routes back to secondary prevention, while stable eradication returns to primary prevention. This system complements existing gastric cancer prevention as a strategic depth extension, providing a scientific, scalable framework for H. pylori prevention and control.]]></description>
<pubDate>2026/6/3 14:43:41</pubDate>
<category><![CDATA[专家论坛]]></category>
<author><![CDATA[Yao Mei Cun]]></author>
</item>
<item>
<title><![CDATA[Molecular Mechanisms and Targets of Vitiligo Induced by Emotional Stress]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202601190000004&flag=2]]></link>
<description><![CDATA[Emotional stress is an emotional response generated by the body due to the impact of life events, social failures, anxiety, tension, and psychological pressure. Clinically, the onset and recurrence of vitiligo are often accompanied by emotional stress, and the pathogenesis of vitiligo induced by emotional stress remains unclear. This review introduced the immune-dependent and immune-independent mechanisms of emotional stress-induced vitiligo, respectively, and summarized the therapeutic targets and the related therapies for ameliorating emotional stress-induced vitiligo, so as to provide a reference for research on the pathogenic mechanism, prevention, and treatment of the emotional stress-induced vitiligo.]]></description>
<pubDate>2026/5/22 13:17:27</pubDate>
<category><![CDATA[综述]]></category>
<author><![CDATA[Chenyanfen,Liuxiaoting,Tangnan,Wangguoen,Zhangqiwen]]></author>
</item>
<item>
<title><![CDATA[Application and Quality Control Requirements of Sucrose in High-Risk Formulations]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202506120000001&flag=2]]></link>
<description><![CDATA[Sucrose is one of the important pharmaceutical excipients in the pharmaceutical industry, traditionally used mainly as a sweetener and bulking agent. High-risk formulations refer to pharmaceutical preparations that are prone to severe adverse reactions due to their specific target populations or unique routes of administration. In this context, sucrose requires special processing techniques and additional quality control measures to meet the specific requirements of these formulations.This article systematically examines the applications of sucrose in high-risk formulations according to administration routes—oral, injectable, and inhalation—detailing its functions and uses in these preparations while clarifying the corresponding quality control requirements. Finally, the development prospects of sucrose for high-risk formulations are discussed.]]></description>
<pubDate>2026/4/24 13:55:23</pubDate>
<category><![CDATA[综述]]></category>
<author><![CDATA[Liu Zhengyu,Sun Chunmeng,Tu Jiasheng,Wang Yaru,Xue Jiaqing]]></author>
</item>
<item>
<title><![CDATA[Pharmacognostical Identification on Four Medicinal plants of Disporopsis]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202507110000006&flag=2]]></link>
<description><![CDATA[Abstract:Objective: To compare and identify the original plants of Disporopsis fuscopicta, D. pernyi，D. longifolia and D. aspersa.and determine their polysaccharide content. Method:The pharmacognostic identification method was employed to compare the morphological characteristics, tissue structures, and microscopic powder features of four medicinal plant species in Disporopsis. and the anthrone-sulfuric acid method was used to determine the polysaccharide content.Result: the primary distinguishing features among these four medicinal plants of the Disporopsis lie in floral morphology (arrangement of corona lobes and perianth segments), rhizome morphology, and fruit color. However, their macroscopic identification, histological microscopy, and powder microscopic characteristics showed no significant differences. Additionally, the polysaccharide content among the four Medicinal plants of Disporopsis did not exhibit notable variations. Conclusion:This study provides reference for the identification, quality standard formulation and revision, as well as resource development and utilization of medicinal plants within the Disporopsis.]]></description>
<pubDate>2026/4/20 14:49:11</pubDate>
<category><![CDATA[实验研究]]></category>
<author><![CDATA[Lin Rong,Lin Yan,Wu Jianguo,WU Yanbin]]></author>
</item>
</channel>
</rss>